🔴 20/20 Biolabs is trading 10.25% down today as hotter-than-expected inflation pressures growth shares

20/20 Biolabs is trading 10.25% lower at $0.32, with the broader market selloff the most likely explanation following hotter-than-expected inflation.

• September CPI rose 3.7% year over year versus 3.6% expected, lifting Treasury yields and pressuring U.S. stocks and growth shares.
• No clear company-specific announcement was found; its previously announced participation in the October 14 Maxim Growth Summit is not an evident negative catalyst.